Roentgen Oncologic Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.34 M
as on 13-12-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 33.68 Cr
as on 13-12-2024
- Revenue -0.16%
(FY 2022)
- Profit 0.73%
(FY 2022)
- Ebitda -51.54%
(FY 2022)
- Net Worth -73.60%
(FY 2022)
- Total Assets -62.11%
(FY 2022)
About Roentgen Oncologic Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.34 M.
The company has closed loans amounting to ₹33.68 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shelley Hukku and Shikha Halder serve as directors at the Company.
- CIN/LLPIN
U85110DL2005PTC135268
- Company No.
135268
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Roentgen Oncologic Solutions?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shikha Halder  | Managing Director | 25-Apr-2005 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shelley Hukku | Director | 25-Apr-2005 | Current |
Financial Performance of Roentgen Oncologic Solutions.
Roentgen Oncologic Solutions Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.16% decrease. The company also saw a slight improvement in profitability, with a 0.73% increase in profit. The company's net worth observed a substantial decline by a decrease of 73.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Roentgen Oncologic Solutions?
In 2022, Roentgen Oncologic Solutions had a promoter holding of 45.95% and a public holding of 54.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 26 Sep 2014 | ₹7.85 Cr | Satisfied |
Ge Capital Services India Creation Date: 16 Apr 2014 | ₹1.00 Cr | Satisfied |
Ge Capital Services India Creation Date: 28 Sep 2012 | ₹7.50 M | Satisfied |
How Many Employees Work at Roentgen Oncologic Solutions?
Roentgen Oncologic Solutions has a workforce of 4 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Roentgen Oncologic Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Roentgen Oncologic Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
